Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
2021 Second quarter results announcement
New GSK Investor update
Emma Walmsley, CEO, and other members of CET hosted a virtual investor update on Wednesday 23 June.
The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.